Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml(-1) in Western China

The goal of this study was to investigate the clinical application of free/total prostate-specific antigen (F/T PSA) ratio, considering the new broad serum total PSA (T-PSA) “gray zone” of 2.0–25.0 ng ml(−1) in differential diagnosis of prostate cancer (PCa) and benign prostate diseases (BPD) in men...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xue-Dan, Miao, Qiang, Zhang, Jun-Long, Zhai, Jian-Zhao, Gui, Xue-Mei, Cai, Yi-Han, Niu, Qian, Cai, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887115/
https://www.ncbi.nlm.nih.gov/pubmed/34916475
http://dx.doi.org/10.4103/aja202182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887115/
https://www.ncbi.nlm.nih.gov/pubmed/34916475
http://dx.doi.org/10.4103/aja202182

Ejemplares similares